SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 63 filers reported holding SILVERBACK THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $91 | -66.0% | 24,072 | -39.8% | 0.00% | -100.0% |
| Q2 2023 | $268 | -18.0% | 39,969 | -20.4% | 0.00% | 0.0% |
| Q1 2023 | $327 | -28.6% | 50,243 | -6.5% | 0.00% | -50.0% |
| Q4 2022 | $458 | -99.9% | 53,714 | -34.5% | 0.00% | 0.0% |
| Q3 2022 | $433,000 | +14.2% | 82,033 | -7.3% | 0.00% | 0.0% |
| Q2 2022 | $379,000 | +27.6% | 88,458 | +4.6% | 0.00% | +100.0% |
| Q1 2022 | $297,000 | -47.3% | 84,566 | -0.2% | 0.00% | -50.0% |
| Q4 2021 | $564,000 | +263.9% | 84,731 | +445.7% | 0.00% | +100.0% |
| Q3 2021 | $155,000 | -68.9% | 15,528 | -3.6% | 0.00% | -50.0% |
| Q2 2021 | $498,000 | -28.0% | 16,108 | +1.6% | 0.00% | -33.3% |
| Q1 2021 | $692,000 | +36.2% | 15,860 | +44.7% | 0.00% | +50.0% |
| Q4 2020 | $508,000 | – | 10,957 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,618,036 | $80,871,000 | 3.02% |
| Orbimed Advisors | 8,740,887 | $270,006,000 | 2.73% |
| Boxer Capital, LLC | 1,675,377 | $51,752,000 | 1.83% |
| Endurant Capital Management LP | 139,124 | $4,298,000 | 1.18% |
| Nantahala Capital Management | 1,266,266 | $39,115,000 | 1.11% |
| COMMODORE CAPITAL LP | 97,143 | $3,001,000 | 1.05% |
| Ally Bridge Group (NY) LLC | 128,572 | $3,972,000 | 0.99% |
| RA Capital Management | 1,742,186 | $53,816,000 | 0.86% |
| HighVista Strategies LLC | 25,906 | $800,000 | 0.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 173,891 | $5,371,000 | 0.36% |